DEA Archived Press Releases

Press Releases before January 20, 2025
622 Results - Showing 391 to 400
PRESS RELEASE

11th Drug Take-Back Announced By DEA

PHOENIX - DEA announced today that the 11th National Prescription Drug Take-Back will take place April 30th from 10 am-2 pm local time. As with the previous 10 Take-Back events, sites will be set up throughout communities nationwide so local residents can anonymously return their unwanted, unneeded, or expired prescription...
PRESS RELEASE

Former Mexican Mayor Gets 21 Years In Prison For Drug Trafficking

PHOENIX - The Drug Enforcement (DEA) today announced that former Fronteras, Sonora, Mexico Mayor Arturo Reyes Trujillo was sentenced to over 21 years in prison for drug trafficking and money laundering. Trujillo was elected municipal (mayor) in Fronteras, Sonora, Mexico in 2012, and was arrested in September of that year...
PRESS RELEASE

DEA Arrests 7 In Sierra Vista Drug Trafficking Ring

TUCSON, Ariz. - DEA announced today the arrest of seven members of the Erick Erives drug trafficking (DTO), as a result of a 28-count indictment acquired through the Arizona Attorney General’s Office, citing multiple drug charges, allegations of money laundering and fraud. Erick Erives, the cell head of the DTO...
PRESS RELEASE

DEA Meets With Pharmaceutical Industry Leaders Today To Discuss Collaboratively Preventing Prescription Drug Misuse And Abuse

WASHINGTON - U.S. Drug Enforcement (DEA) Acting Administrator Chuck Rosenberg and the Chief of DEA’s Office of Diversion Control, Lou Milione hosted a meeting today in Washington with industry leaders representing the prescription drug supply chain in America. The purpose of their dialogue was to discuss ways to minimize pharmaceutical...
PRESS RELEASE

DEA Administrator Chuck Rosenberg Statement On Walgreens’ Prescription Drug Take Back Initiative

WASHINGTON - The United States Drug Enforcement (DEA) commends Walgreens for their commitment to install secure collection bins for unused prescription drugs in over 500 of their stores in 40 states. "Take back programs are an important and easy way for the public to anonymously dispose of their unwanted, unused...
PRESS RELEASE

FBI, DEA Release Documentary Film Addressing Heroin/Prescription Drug Abuse

WASHINGTON - In an effort to combat the growing epidemic of prescription drug and heroin abuse, leaders of the FBI and DEA today unveiled a documentary aimed at educating students and young adults about the dangers of the addiction. “Chasing the Dragon” is a 45-minute documentary film that profiles the...
PRESS RELEASE

DEA And European Authorities Uncover Massive Hizballah Drug And Money Laundering Scheme

WASHINGTON - The United States Drug Enforcement (DEA) today announced significant enforcement activity including arrests targeting Lebanese Hizballah’s External Security Organization Business Affairs (BAC), which is involved in international criminal activities such as drug trafficking and drug proceed money laundering. These proceeds are used to purchase weapons for Hizballah for...
PRESS RELEASE

Leader Of Mexican Drug Trafficking Organization Sentenced To 11 Years Prison

PHOENIX - DEA announced today, the sentencing of Carlos Ramon Castro-Rocha, 42, of Los Mochis, Sinaloa, Mexico, to 11 years in prison. Castro-Rocha, a former Consolidated Priority Organization (CPOT), a term designated as a reference to the highest-level drug traffickers, previously pleaded guilty to conspiracy to possess heroin with intent...
PRESS RELEASE

DEA Statement On The Capture Of Joaquin “Chapo” Guzman-Loera

WASHINGTON - The capture of Joaquin “Chapo” Guzman-Loera is a victory for the rule of law and the Mexican people and government. The arrest is a significant achievement in our shared fight against transnational organized crime, violence, and drug trafficking. It is further evidence of our two countries’ resolve to...
PRESS RELEASE

DEA Eases Requirements For FDA-Approved Clinical Trials On Cannabidiol

WASHINGTON - The United States Drug Enforcement (DEA) recently eased some of the regulatory requirements imposed by the Controlled Substances (CSA) for those who are conducting FDA-approved clinical trials on (CBD), an extract of the marijuana plant. These modifications will streamline the research process regarding CBD’s possible medicinal value and...